Retour
Fourchette du Jour
47,00 €
49,18 €
Fourchette 52 Semaines
6,71 €
53,65 €
Volume
512 668
Moyenne 50J / 200J
45,69 €
/
29,72 €
Clôture Précédente
48,03 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 45,1 | 0,4 |
| P/B | 12,0 | 2,9 |
| ROE % | 50,5 | 3,7 |
| Net Margin % | 31,2 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Points Clés
ROE of 50,47% indicates high profitability
Net margin of 31,18% shows strong profitability
Debt/Equity of 0,14 — conservative balance sheet
Generating 74,81M in free cash flow
P/E of 45,14 — premium valuation
Cash machine — converts 143,22% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
50,47%
ROIC19,32%
Net Margin31,18%
Op. Margin34,38%
Sécurité
Debt / Equity
0,14
Current Ratio9,76
Interest Coverage0,00
Valorisation
P/E Ratio
45,14
P/B Ratio11,97
EV/EBITDA37,99
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 167,50M | Net Income (TTM) | 52,23M |
| ROE | 50,47% | ROA | 21,71% |
| Gross Margin | 100,00% | Operating Margin | 34,38% |
| Net Margin | 31,18% | Free Cash Flow (TTM) | 74,81M |
| ROIC | 19,32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 9,76 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 45,14 | P/B Ratio | 11,97 |
| P/S Ratio | 14,08 | PEG Ratio | -0,13 |
| EV/EBITDA | 37,99 | Dividend Yield | 0,00% |
| Market Cap | 2,36B | Enterprise Value | 2,19B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 167,50M | 0,0 | 0,0 |
| Net Income | 52,23M | -100,42M | -114,94M |
| EPS (Diluted) | 0,08 | -2,29 | -2,63 |
| Gross Profit | 167,50M | 0,0 | 0,0 |
| Operating Income | 57,59M | -98,55M | -111,03M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 240,54M | 71,50M | 149,96M |
| Total Liabilities | 43,64M | 61,45M | 48,51M |
| Shareholders' Equity | 196,90M | 10,05M | 101,44M |
| Total Debt | 26,63M | 49,62M | 32,06M |
| Cash & Equivalents | 196,81M | 29,16M | 99,92M |
| Current Assets | 201,67M | 34,11M | 106,15M |
| Current Liabilities | 20,67M | 16,32M | 20,78M |